This cross-sectional study assesses buprenorphine coverage and prior authorization requirements in US commercial formulary data from 2017 to 2021.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270692 | PMC |
| http://dx.doi.org/10.1001/jamahealthforum.2022.1821 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
State Medicaid Policies Governing Access to Medications for Opioid Use Disorder (MOUD) and MOUD Treatment Use in a Large Sample of People Who Inject Drugs in 20 U.S. States.
Subst Use Misuse
December 2024
Department of Health Policy and Management, Rollins School of Public Health at Emory University, Atlanta, GA, USA.
Background: People who inject drugs (PWID) are especially vulnerable to harms from opioid use disorder (OUD). Medications for OUD (MOUD) effectively reduce overdose and infectious disease transmission risks.
Objective: We investigate whether state Medicaid coverage for methadone and buprenorphine is related to past-year MOUD use among PWID using cross-sectional, multilevel analyses with individual-level data on PWID from the Centers for Disease Control and Prevention's 2018 National HIV Behavioral Surveillance.
The Effect of Out-of-Pocket Costs on Medications for Opioid Use Disorder and Overdose: A Scoping Review.
J Am Pharm Assoc (2003)
December 2024
College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, NS, Canada. Electronic address:
Background: The opioid epidemic is a major public health crisis in Canada and elsewhere. The increase in opioid prescriptions is a major contributor to this crisis. Medications for opioid use disorder (OUD) and overdose are effective and life saving treatments.
View Article and Find Full Text PDFRedefining low-threshold buprenorphine access in an integrated mobile clinic program: Factors associated with treatment retention.
J Subst Use Addict Treat
February 2025
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD, USA; Baltimore City Health Department, Baltimore, MD, USA. Electronic address:
Introduction: The Spot mobile clinic provides low-threshold buprenorphine integrated with clinical and social services in Baltimore City, MD. In 2021, The Spot modified practices to improve engagement including providing extended prescriptions, reducing frequency of toxicology testing, giving up to six months to stabilize on medication, offering maximum doses (up to 32 mg total) daily, and utilizing telemedicine. This study characterizes care retention by examining both the total time in care and the percentage of time with buprenorphine prescription coverage during these practice changes, and examines factors associated with retention.
View Article and Find Full Text PDFEffects Of Medicaid Waivers On Use Of Medications For Opioid Use Disorder And Nonfatal Overdoses In 17 States.
Health Aff (Millwood)
November 2024
K. John McConnell, Oregon Health & Science University.
A long-standing policy prohibits the use of federal funds for Medicaid services in Institutions for Mental Diseases (facilities with more than sixteen beds that specialize in mental health or substance use disorder treatment). Beginning in 2015, states could apply for Section 1115 Medicaid waivers, which permit federal funding for Institutions for Mental Diseases services and require improvements in opioid use disorder (OUD) treatment. Using 2016-20 Medicaid data, we compared changes in the use of medications for OUD and nonfatal overdoses in seventeen states with waivers approved during 2017-19 to changes in eighteen states without waivers.
View Article and Find Full Text PDFIncreasing medication assisted treatment in rural primary care practice: a qualitative comparative analysis from IT MATTTRs Colorado.
Front Med (Lausanne)
October 2024
Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Purpose: Opioid dependence and use disorders (OUDs) are serious public health crises resulting in a rising number of opioid-related deaths. Medication assisted treatment (MAT), in this case treatment with buprenorphine, is an evidence-based solution to combatting OUD; however, MAT has been largely unavailable in rural areas. This study investigated what it took to increase MAT in rural Colorado primary care practices.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!